NO20073256L - Vaccines against meningococcus - Google Patents
Vaccines against meningococcusInfo
- Publication number
- NO20073256L NO20073256L NO20073256A NO20073256A NO20073256L NO 20073256 L NO20073256 L NO 20073256L NO 20073256 A NO20073256 A NO 20073256A NO 20073256 A NO20073256 A NO 20073256A NO 20073256 L NO20073256 L NO 20073256L
- Authority
- NO
- Norway
- Prior art keywords
- fragment
- variant
- vaccines against
- against meningococcus
- polypeptide
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 239000012634 fragment Substances 0.000 abstract 3
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 230000004927 fusion Effects 0.000 abstract 2
- 241000588650 Neisseria meningitidis Species 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Det er beskrevet ulike polypeptider, eller en variant eller fragment av det, eller en fusjon av disse, som er nyttige i en vaksine. Polypeptidet kan være et polypeptid omfattende aminosyre-sekvensen valgt fra en av SEQ ID Nos 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68; eller et fragment eller variant av det, eller en fusjon av et slikt fragment eller variant, og er nyttig i en vaksine mot Neisseria meningitidis.Various polypeptides, or a variant or fragment thereof, or a fusion thereof are disclosed which are useful in a vaccine. The polypeptide may be a polypeptide comprising the amino acid sequence selected from one of SEQ ID Nos 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68; or a fragment or variant thereof, or a fusion of such fragment or variant, and is useful in a vaccine against Neisseria meningitidis.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/GB2004/005441 WO2005060995A2 (en) | 2003-12-23 | 2004-12-23 | Identification of antigenically important neisseria antigens by screening insertional mutant libraries with antiserum |
| PCT/GB2005/005113 WO2006067518A2 (en) | 2004-12-23 | 2005-12-23 | Vaccines against neisseria meningitidis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20073256L true NO20073256L (en) | 2007-09-17 |
Family
ID=36282716
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20073256A NO20073256L (en) | 2004-12-23 | 2007-06-25 | Vaccines against meningococcus |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1848457A2 (en) |
| JP (1) | JP2008525008A (en) |
| KR (1) | KR20070094762A (en) |
| CN (2) | CN101115502A (en) |
| AU (1) | AU2005317835A1 (en) |
| CA (1) | CA2592156A1 (en) |
| MX (1) | MX2007007886A (en) |
| NO (1) | NO20073256L (en) |
| RU (1) | RU2007127921A (en) |
| WO (1) | WO2006067518A2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1976556A2 (en) * | 2005-12-23 | 2008-10-08 | Imperial Innovations Limited | Neisseria meningitidis vaccines and their use |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9814902D0 (en) * | 1998-07-10 | 1998-09-09 | Univ Nottingham | Screening of neisserial vaccine candidates against pathogenic neisseria |
-
2005
- 2005-12-23 MX MX2007007886A patent/MX2007007886A/en unknown
- 2005-12-23 RU RU2007127921/13A patent/RU2007127921A/en not_active Application Discontinuation
- 2005-12-23 EP EP05823115A patent/EP1848457A2/en not_active Withdrawn
- 2005-12-23 KR KR1020077015481A patent/KR20070094762A/en not_active Application Discontinuation
- 2005-12-23 CA CA002592156A patent/CA2592156A1/en not_active Abandoned
- 2005-12-23 JP JP2007547670A patent/JP2008525008A/en active Pending
- 2005-12-23 WO PCT/GB2005/005113 patent/WO2006067518A2/en active Application Filing
- 2005-12-23 CN CNA2005800479621A patent/CN101115502A/en active Pending
- 2005-12-23 AU AU2005317835A patent/AU2005317835A1/en not_active Abandoned
-
2006
- 2006-12-21 CN CNA2006800516894A patent/CN101370514A/en active Pending
-
2007
- 2007-06-25 NO NO20073256A patent/NO20073256L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006067518A3 (en) | 2006-11-23 |
| CA2592156A1 (en) | 2006-06-29 |
| EP1848457A2 (en) | 2007-10-31 |
| WO2006067518A2 (en) | 2006-06-29 |
| RU2007127921A (en) | 2009-01-27 |
| MX2007007886A (en) | 2008-01-16 |
| KR20070094762A (en) | 2007-09-21 |
| JP2008525008A (en) | 2008-07-17 |
| CN101370514A (en) | 2009-02-18 |
| AU2005317835A1 (en) | 2006-06-29 |
| CN101115502A (en) | 2008-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1106875T1 (en) | NEISSERIA ANTIGONAL PIPES | |
| NO20063026L (en) | antibodies | |
| GB2439474A (en) | LI-Key/Antigenic epitope hybrid peptide vaccines | |
| DK1093517T3 (en) | Neisseria meningitidis antigens and preparations | |
| ATE397068T1 (en) | ANTIGEN MENINGOCOCCAL PEPTIDES | |
| NO20050008L (en) | Neisserial vaccine compositions comprising a combination of antigens | |
| EP2289545A3 (en) | Supplemented OMV vaccine against meningococcus | |
| DK1185691T3 (en) | Genomic neonatal sequences and methods for their use | |
| ATE476508T1 (en) | NEISSERIAL ANTIGENS | |
| DK1904529T3 (en) | Use of Stefin A as a Scaffold Protein | |
| WO2009025117A1 (en) | Cdca1 peptide and pharmaceutical agent comprising the same | |
| DK1328547T3 (en) | Identification and modification of immunodominant epitopes in polypeptides | |
| DE602004025943D1 (en) | MIKROSOMVAKZIN | |
| ATE551069T1 (en) | MUCIN FUSION POLYPEPTIDE VACCINES, COMPOSITIONS AND USE THEREOF | |
| ATE457352T1 (en) | SUBTILISIN CARLSBERG PROTEINS WITH REDUCED IMMUNOGENICITY | |
| EP1932915A3 (en) | Materials and methods relating to improved vaccination strategies | |
| WO2000012535A3 (en) | Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof | |
| DK1214088T3 (en) | Proteins expressed by Mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines | |
| NO20073256L (en) | Vaccines against meningococcus | |
| DK1913020T3 (en) | Immunogenic constructs | |
| DE602004028266D1 (en) | ANGIOGENIC PEPTIDES AND ITS USES | |
| NO20082810L (en) | Vaccine, and use of the same | |
| NO20005081D0 (en) | A polypeptide containing the amino acid of an N-terminal choline binding protein A-truncate, vaccine derived therefrom and uses thereof | |
| NZ597291A (en) | Peptides that mimic non-human cross-reactive protective epitopes of the group b meningococcal capsular polysaccharide | |
| WO2006027584A3 (en) | Vaccines against neisseria |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |